Counterfeit Drug Sales Will Double By 2010, Former FDAer Pitts Predicts
Executive Summary
Counterfeit drug sales are growing at nearly twice the rate of those for genuine pharmaceutical products, according to a report by former FDA Associate Commissioner for External Relations Peter Pitts
You may also be interested in...
Importation Limits In Future Trade Agreements Prevented Under Vitter Bill
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
FDA Anticounterfeit Carrot & Stick: Radio Frequency I.D., No Paper Pedigree
FDA's anticounterfeiting strategy advocates radio frequency identification in lieu of paper pedigrees to secure the drug supply chain
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011